Log In
BCIQ
Print this Print this
 

Lumiralin (AM-21)

  Manage Alerts
Collapse Summary General Information
Company Microlin Bio Inc.
DescriptionAnti-microRNA-21 (miR-21)
Molecular Target MicroRNA-21 (miR-21)
Mechanism of ActionMicroRNA-21 (miR-21) inhibitor
Therapeutic ModalityNucleic acid: Linear RNA: microRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationLung cancer
Indication DetailsTreat lung cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/22/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today